These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1361480)

  • 1. C-erbB-2-oncogene expression in breast carcinoma: analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters.
    Tanner B; Friedberg T; Mitze M; Beck T; Oesch F; Knapstein PG
    Gynecol Oncol; 1992 Nov; 47(2):228-33. PubMed ID: 1361480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry.
    Dawkins HJ; Robbins PD; Sarna M; Carrello S; Harvey JM; Sterrett GF
    Pathology; 1993 Apr; 25(2):124-32. PubMed ID: 8103591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between c-erb beta-2 oncogene amplification and the expression of its mRNA and protein in human breast carcinomas.
    Bandyopadhyay D; Dani HD; Samant UC; Redkar AA; Mittra I
    Oncology; 1992; 49(1):9-14. PubMed ID: 1347417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of c-erB-2 mRNA in ovarian carcinoma.
    Tanner B; Kreutz E; Weikel W; Meinert R; Oesch F; Knapstein PG; Becker R
    Gynecol Oncol; 1996 Aug; 62(2):268-77. PubMed ID: 8751560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
    Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
    Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
    J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
    Paik S; Hazan R; Fisher ER; Sass RE; Fisher B; Redmond C; Schlessinger J; Lippman ME; King CR
    J Clin Oncol; 1990 Jan; 8(1):103-12. PubMed ID: 1967301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
    Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
    Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of erbB-2/neu levels in tissue.
    Paik S; King CR; Simpson S; Lippman ME
    Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.
    Nugent A; McDermott E; Duffy K; O'Higgins N; Fennelly JJ; Duffy MJ
    Clin Chem; 1992 Aug; 38(8 Pt 1):1471-4. PubMed ID: 1353709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Cancer; 1992 Jun; 69(12):2953-60. PubMed ID: 1350504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
    Nagai MA; Marques LA; Torloni H; Brentani MM
    Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.